Natco seeks to block Gilead's hepatitis C drug patent in India: source
MUMBAI (Reuters) - India's Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's new hepatitis C d...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/r1GC9E-dKlc/story01.htm
No comments:
Post a Comment